For details on the research programs of our faculty, please visit the individual webpages under the "Faculty" tab.  Selected highlights of our campus-wide, multidisciplinary, or multicenter research programs can be accessed by clicking on the respective links below.

2016 Static smaller

The Comprehensive Arthritis, Musculoskeletal, Bone and Autoimmunity Center (CAMBAC) (S. Louis Bridges, Jr, MD, PhD, Director) is dedicated to generating new knowledge and to applying such to the diagnosis and treatment of patients with arthritis, musculoskeletal and autoimmune diseases. This charge includes integrating and promoting fundamental research with clinical care, developing and applying new diagnostics and therapeutics, educating the public about arthritis, musculoskeletal, and autoimmune diseases, and training future investigators and health care professionals.

(Center for Outcomes and Effectiveness Research and Education). The mission of the UAB COERE is to build and maintain a successful program of research targeted at improving the quality and outcomes of health care. COERE is directed by Kenneth Saag, MD, MSc, Professor of Medicine in the Division of Clinical Immunology & Rheumatology.

The NIAMS MCRC (Multidisciplinary Clinical Research Center). Directed by S. Louis Bridges, Jr, MD, PhD, Division of Clinical Immunology & Rheumatology is a program designed to foster and promote research related to the causes, diagnosis, treatment, and improved care of patients suffering from arthritis and musculoskeletal diseases (MSD). To this end, highly-rigorous fundamental and clinical research is supported with state-of-the-art methodology with the following mission: (1) To conduct outstanding, innovative research projects drawing on the unique strengths of the AMC and using state-of-the-art tools from statistics, epidemiology, outcomes, health services, and behavioral research; (2) To foster the development of new projects and the development and application of new evaluative, analytic, and translational methods to research in arthritis and MSD; (3) To promote the training of new, and the continuing education of established, clinical investigators in the most current methods of research and evaluation applicable to arthritis and MSD

The UAB Rheumatology Arthritis Database and Repository (RADAR) (S. Louis Bridges, Jr, MD, PhD, Principal Investigator) . Manual of Operations acts as a guide to the Investigators and Coordinators regarding the day-to-day conduct of study protocol. This protocol maintains Human Subjects Research approval, issued by the UAB OIRB. Please click here to access the Manual of Operarions. 

Mod RDCC Logo
To complement ongoing research, the RDCC (Rheumatic Diseases Core Center), (NIH/NIAMS 5P30 AR048311) directed by John Mountz, MD, PhD, has a strong obligation to provide access to innovative experimental methodologies. As such, the RDCC supports three scientific cores: (1) Comprehensive Flow Cytometry Core (CFCC) directed by John D. Mountz, MD, PhD; (2) Analytic Imaging and Immunoreagent Core (AIIC) directed by Kent T. Keyser, PhD; and (3) Analytical Genomics and Transgenics Core (AGTC) Facility directed by Robert A. Kesterson, PhD.

UAB Center of Research Translation (CORT) (Kenneth G. Saag, MD, MSc, Director; Hyon Choi, MD, DrPH, Co-Director; S. Louis Bridges, Jr, MD, PhD, Co-Director; 2P50AR060772). Gout impacts around 4% of the U.S. adult population and is the most common form of inflammatory arthritis in men. The incidence of gout is increasing worldwide and may be as high as 9% in the elderly. Gout is a significant burden on the healthcare system, and is associated with both decreased work productivity and quality of life. With the ever-increasing impact of gout and its associated comorbidities on the population, investigation of novel translational mechanisms mediating gout flares as well as approaches to improving gout and hyperuricemia outcomes comprise an unmet and urgent medical need. The INvestigationS In Gout, Hyperuricemia, and comorbidiTies (INSIGHT) Center of Research Translation (CORT) is comprised of an administrative core and 4 research projects focused on the themes, “Gout, Hyperuricemia, and Associated Comorbidities”. The goal for the INSIGHT CORT is to improve the healthcare of patients and reduce the societal burden of gout and hyperuricemia by applying scientifically rigorous, state-of-the-art methodology to clinically important translational research questions.

  Click here for information about our Pilot RFA Announcement (Letter of Intent Due: 12 June 2018)

ACIP (Arthritis Clinical Intervention Program). ACIP is a full service clinical trial unit that conducts studies in rheumatology (Phase I-IV). Current studies focus on rheumatoid arthritis (RA), gout, scleroderma, lupus and vasculitis. Jeffrey Curtis, MD, MS, MPH,  is the Medical Director of this program.

Smallest Wallet Card Image VERVEThe Varicella zostER VaccinE Study (VERVE) has been approved by the Food and Drug Administration (FDA). The University of Alabama at Birmingham (UAB) is coordinating the VERVE study. For more information, please Click here

SOM Epilogue Menu